A continuation phase after the controlled part of a trial, where everyone knows they are receiving the compound. Useful for long-term safety, weak as efficacy evidence, because the blinding is gone.
A continuation phase after the controlled part of a trial, where everyone knows they are receiving the compound. Useful for long-term safety, weak as efficacy evidence, because the blinding is gone.
Stay current
No membership required. We email findings when they're published. Not updates, not promotions, just reports.
Powered by MailerLite. No spam. Unsubscribe anytime.